// App-Quantinova.ai

486 : Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer.

Researchers

Presenter

  • Satoshi Matsusaka

Principal Investigators

  • Mitsukuni Suenaga

  • Yuji Mishima

  • Yasuhito Terui

  • Eiji Shinozaki

  • Nobuyuki Mizunuma

  • Kiyohiko Hatake

Medical Centers

  • Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan

  • Department of Medical Oncology of Cancer Institute Hospital, Clinical Chemotherapy, Cancer Chemotherapy Center of Japanese Foundation for Cancer Research, Tokyo, Japan

  • Department of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Oxaliplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved